Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2012 3
2013 5
2014 5
2015 3
2016 12
2017 7
2018 13
2019 23
2020 33
2021 18
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33246978

102 results
Results by year
Filters applied: . Clear all
Page 1
Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using 18F-FDG PET/CT: multicenter study for comparison of EORTC, PERCIST, and imPERCIST.
Kitajima K, Watabe T, Nakajo M, Ishibashi M, Daisaki H, Soeda F, Tanemura A, Kanekura T, Yamazaki N, Ito K. Kitajima K, et al. Jpn J Radiol. 2021 Jul 21. doi: 10.1007/s11604-021-01174-w. Online ahead of print. Jpn J Radiol. 2021. PMID: 34287739
Can 3'-deoxy-3'-(18)F-fluorothymidine or 2'-deoxy-2'-(18)F-fluoro-d-glucose PET/CT better assess response after 3-weeks treatment by epidermal growth factor receptor kinase inhibitor, in non-small lung cancer patients? Preliminary results.
Bhoil A, Singh B, Singh N, Kashyap R, Watts A, Sarika S, Mittal BR. Bhoil A, et al. Hell J Nucl Med. 2014 May-Aug;17(2):90-6. doi: 10.1967/s002449910136. Epub 2014 Jul 5. Hell J Nucl Med. 2014. PMID: 24997081 Clinical Trial.
102 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page